Clinical Trial Update: Mood Disorders in Head and Neck Cancer Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating mood disorders in head and neck cancer patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Head and Neck Cancer

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Depressive Disorder, Head and Neck Cancer | Phase 4 | Status: WITHDRAWN